Concord Biotech Limited

NSE CONCORDBIO.NS

Concord Biotech Limited Revenue for the year ending March 31, 2024: USD 119.66 M

Concord Biotech Limited Revenue is USD 119.66 M for the year ending March 31, 2024, a 15.27% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Concord Biotech Limited Revenue for the year ending March 31, 2023 was USD 103.80 M, a 11.26% change year over year.
  • Concord Biotech Limited Revenue for the year ending March 31, 2022 was USD 93.30 M, a 13.10% change year over year.
  • Concord Biotech Limited Revenue for the year ending March 31, 2021 was USD 82.50 M, a 21.34% change year over year.
  • Concord Biotech Limited Revenue for the year ending March 31, 2020 was USD 67.99 M.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
SV Wall Street
NSE: CONCORDBIO.NS

Concord Biotech Limited

CEO Mr. Ankur Vaid
IPO Date Aug. 18, 2023
Location India
Headquarters 16th Floor, B-Wing
Employees 1,377
Sector Health Care
Industries
Description

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. It provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. The company also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment; mupirocin, mupirocin calcium, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, and micafungin sodium for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

StockViz Staff

February 6, 2025

Any question? Send us an email